B.C. restricts sale of Ozempic after prescription scheme drives surge in demand from U.S. | Canada News Media
Connect with us

Business

B.C. restricts sale of Ozempic after prescription scheme drives surge in demand from U.S.

Published

 on

British Columbia is introducing a new regulation to stop online and mail-order sales of diabetes drug Ozempic to people who do not live in Canada or who are not in B.C. to make the purchase in person.

The changes come after it was discovered a doctor in Texas with a Nova Scotia medical licence wrote 17,000 Ozempic prescriptions in three months to mostly American patients. The majority of those prescriptions were filled at two B.C. online pharmacies where the drug costs much less.

Ozempic is an injectable medication for Type-2 diabetes that has become wildly popular through advertising and social media influencers as an off-label weight loss drug. On TikTok, #Ozempic has reached over 850 million views.

“We do not bring drugs into B.C. to have them re-exported to the United States in response to whatever advertising campaigns are in place or word-of-mouth discussions,” said Health Minister Adrian Dix. “The purpose of this regulation is to protect supply and access to semaglutide drugs that treat Type-2 diabetes.”

B.C. does not have a shortage of Ozempic, said Dix, but the surge in sales to U.S. residents was leading to shortages in other jurisdictions. Ozempic purchased in B.C. is significantly less expensive than buying it south of the border.

Cheaper in B.C.

According to figures provided by the Ministry of Health, the average cost of Ozempic for someone in B.C. is approximately $300 per month. That compares to reported prices in the U.S. ranging from $900-$1200 US (approximately $1,200 to $1,600 Cdn) depending on dose, said the ministry.

Dix said the difference in cost is due to Canada’s public health care and B.C.’s negotiated bulk buy purchasing.

The regulations announced Wednesday are effective immediately and will also restrict the sales of other semaglutide drugs, Rybelsus and Wegovy.

Ozempic is pictured in a file photo from May 2022. (Shutterstock)

Dix said other drugs can be added to the restricted sales list if needed but is calling for federal action on the issue of Americans turning to Canada for cheaper prescription drugs so it doesn’t turn into what he described as a  “whack-a-mole situation.”

“This is about the international trade of products that are of essential need in Canada. There is a significant federal role here, and I have written to my colleagues, including the federal minister of health, to ask us to take joint action,” he said.

B.C.’s PharmaNet system, which tracks dispensed drugs provincewide, registered 13,179 Ozempic dispenses from two online pharmacies based in B.C. in January and February of this year, a full 88 per cent of all of the drug dispensed to people south of the border during that period.

Although dispensing to foreigners is not illegal, the B.C. College of Pharmacists has launched an investigation, said Dix.

Nova Scotia-registered Dr. David Davidson had his licence suspended on an interim basis by that province’s regulator last month. Davidson is alleged to have written 3,860 Ozempic prescriptions in December 2022, 5,800 in January 2023, and 7,500 in February 2023.

 

Source link

Continue Reading

Business

Japan’s SoftBank returns to profit after gains at Vision Fund and other investments

Published

 on

 

TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.

Tokyo-based SoftBank Group Corp. reported Tuesday a fiscal second quarter profit of nearly 1.18 trillion yen ($7.7 billion), compared with a 931 billion yen loss in the year-earlier period.

Quarterly sales edged up about 6% to nearly 1.77 trillion yen ($11.5 billion).

SoftBank credited income from royalties and licensing related to its holdings in Arm, a computer chip-designing company, whose business spans smartphones, data centers, networking equipment, automotive, consumer electronic devices, and AI applications.

The results were also helped by the absence of losses related to SoftBank’s investment in office-space sharing venture WeWork, which hit the previous fiscal year.

WeWork, which filed for Chapter 11 bankruptcy protection in 2023, emerged from Chapter 11 in June.

SoftBank has benefitted in recent months from rising share prices in some investment, such as U.S.-based e-commerce company Coupang, Chinese mobility provider DiDi Global and Bytedance, the Chinese developer of TikTok.

SoftBank’s financial results tend to swing wildly, partly because of its sprawling investment portfolio that includes search engine Yahoo, Chinese retailer Alibaba, and artificial intelligence company Nvidia.

SoftBank makes investments in a variety of companies that it groups together in a series of Vision Funds.

The company’s founder, Masayoshi Son, is a pioneer in technology investment in Japan. SoftBank Group does not give earnings forecasts.

___

Yuri Kageyama is on X:

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Trump campaign promises unlikely to harm entrepreneurship: Shopify CFO

Published

 on

 

Shopify Inc. executives brushed off concerns that incoming U.S. President Donald Trump will be a major detriment to many of the company’s merchants.

“There’s nothing in what we’ve heard from Trump, nor would there have been anything from (Democratic candidate) Kamala (Harris), which we think impacts the overall state of new business formation and entrepreneurship,” Shopify’s chief financial officer Jeff Hoffmeister told analysts on a call Tuesday.

“We still feel really good about all the merchants out there, all the entrepreneurs that want to start new businesses and that’s obviously not going to change with the administration.”

Hoffmeister’s comments come a week after Trump, a Republican businessman, trounced Harris in an election that will soon return him to the Oval Office.

On the campaign trail, he threatened to impose tariffs of 60 per cent on imports from China and roughly 10 per cent to 20 per cent on goods from all other countries.

If the president-elect makes good on the promise, many worry the cost of operating will soar for companies, including customers of Shopify, which sells e-commerce software to small businesses but also brands as big as Kylie Cosmetics and Victoria’s Secret.

These merchants may feel they have no choice but to pass on the increases to customers, perhaps sparking more inflation.

If Trump’s tariffs do come to fruition, Shopify’s president Harley Finkelstein pointed out China is “not a huge area” for Shopify.

However, “we can’t anticipate what every presidential administration is going to do,” he cautioned.

He likened the uncertainty facing the business community to the COVID-19 pandemic where Shopify had to help companies migrate online.

“Our job is no matter what comes the way of our merchants, we provide them with tools and service and support for them to navigate it really well,” he said.

Finkelstein was questioned about the forthcoming U.S. leadership change on a call meant to delve into Shopify’s latest earnings, which sent shares soaring 27 per cent to $158.63 shortly after Tuesday’s market open.

The Ottawa-based company, which keeps its books in U.S. dollars, reported US$828 million in net income for its third quarter, up from US$718 million in the same quarter last year, as its revenue rose 26 per cent.

Revenue for the period ended Sept. 30 totalled US$2.16 billion, up from US$1.71 billion a year earlier.

Subscription solutions revenue reached US$610 million, up from US$486 million in the same quarter last year.

Merchant solutions revenue amounted to US$1.55 billion, up from US$1.23 billion.

Shopify’s net income excluding the impact of equity investments totalled US$344 million for the quarter, up from US$173 million in the same quarter last year.

Daniel Chan, a TD Cowen analyst, said the results show Shopify has a leadership position in the e-commerce world and “a continued ability to gain market share.”

In its outlook for its fourth quarter of 2024, the company said it expects revenue to grow at a mid-to-high-twenties percentage rate on a year-over-year basis.

“Q4 guidance suggests Shopify will finish the year strong, with better-than-expected revenue growth and operating margin,” Chan pointed out in a note to investors.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:SHOP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

RioCan cuts nearly 10 per cent staff in efficiency push as condo market slows

Published

 on

 

TORONTO – RioCan Real Estate Investment Trust says it has cut almost 10 per cent of its staff as it deals with a slowdown in the condo market and overall pushes for greater efficiency.

The company says the cuts, which amount to around 60 employees based on its last annual filing, will mean about $9 million in restructuring charges and should translate to about $8 million in annualized cash savings.

The job cuts come as RioCan and others scale back condo development plans as the market softens, but chief executive Jonathan Gitlin says the reductions were from a companywide efficiency effort.

RioCan says it doesn’t plan to start any new construction of mixed-use properties this year and well into 2025 as it adjusts to the shifting market demand.

The company reported a net income of $96.9 million in the third quarter, up from a loss of $73.5 million last year, as it saw a $159 million boost from a favourable change in the fair value of investment properties.

RioCan reported what it says is a record-breaking 97.8 per cent occupancy rate in the quarter including retail committed occupancy of 98.6 per cent.

This report by The Canadian Press was first published Nov. 12, 2024.

Companies in this story: (TSX:REI.UN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version